{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T19:54:48Z","timestamp":1769802888254,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Research and Development Program of Lvliang","award":["2022SHFZ19"],"award-info":[{"award-number":["2022SHFZ19"]}]},{"name":"Key Scientific and Technological Projects of Fenyang Hospital of Shanxi Province","award":["2024005"],"award-info":[{"award-number":["2024005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Given that hyperuricemia is a metabolic condition with a prolonged asymptomatic period and strong associations with gout and various metabolic disorders, we investigated the role of lymphocyte subsets in asymptomatic hyperuricemia (aHUA) and explored their potential implications for immune regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The study enrolled 59 male patients with aHUA, 29 with acute gout (AG), and 28 healthy male controls (HCs). Laboratory data, including blood cell counts, inflammatory markers, blood lipids, liver and renal function, and the percentage and absolute counts of lymphocytes and CD4\u2009+\u2009T cell subpopulations in peripheral blood, were collected. We used flow cytometry to assess the peripheral blood lymphocyte subsets in these participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were significant differences in GGT levels among all three groups, with the aHUA group showing the lowest value (AG vs. aHUA vs. HC, 69.00 vs. 23.00 vs. 35.50;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The lymphocyte subset data revealed a significant increase in the counts of helper T2 (Th2) (AG vs. aHUA vs. HC, 10.73 vs. 10.63 vs. 5.78;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), Th17 (AG vs. aHUA vs. HC, 16.86 vs. 10.23 vs. 7.78;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and T suppressor (Ts) cells (AG vs. aHUA vs. HC, 669.32 vs. 655.00 vs. 488.84;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023), as well as the Th17\/Treg ratio (AG vs. aHUA vs. HC, 0.44 vs. 0.37 vs. 0.26;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) in both aHUA and AG groups. Furthermore, the increase in Th17 cells and the Th17\/Treg ratio was more pronounced in the AG group. Total T cell levels were higher in both the aHUA and AG groups than in HCs, with the aHUA group showing the highest levels (statistically significant versus HCs) (AG vs. aHUA vs. HC, 1517.00 vs. 1620.00 vs. 1316.10;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Furthermore, the univariate regression analysis suggests that GGT [OR (95% CI)\u2009=\u20091.132 (1.069, 1.198),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001], Th17 [OR (95% CI)\u2009=\u20091.228 (1.104, 1.366),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001], and the Th17\/Treg ratio [OR (95% CI)\u2009=\u200918.900 (1.892, 188.833),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012] are positively associated with acute gout flare. Multivariate regression analysis indicated that GGT [OR (95% CI)\u2009=\u20091.113 (1.049, 1.181),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001] and Th17 [OR (95% CI)\u2009=\u20091.235 (1.033, 1.476),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.020] are positively correlated with acute gout flare.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study highlights significant alterations in lymphocyte subsets in aHUA, emphasizing their potential role in the immune response and providing insights for future therapeutic strategies.<\/jats:p>\n                    <jats:p>\n                      <jats:table-wrap>\n                        <jats:table>\n                          <jats:tbody>\n                            <jats:tr>\n                              <jats:td align=\"left\" colspan=\"2\">\n                                <jats:bold>Key Points<\/jats:bold>\n                                \u2022\n                                <jats:italic>Th17 elevation and Th17\/Treg imbalance in asymptomatic hyperuricemia (aHUA) suggest early immune dysregulation.<\/jats:italic>\n                                \u2022\n                                <jats:italic>Th17 cell levels and GGT are positively associated with acute gout flares, serving as biomarkers of disease activity.<\/jats:italic>\n                                \u2022\n                                <jats:italic>Both aHUA and gout patients show immune activation, while there were immunological differences across groups.<\/jats:italic>\n                              <\/jats:td>\n                            <\/jats:tr>\n                          <\/jats:tbody>\n                        <\/jats:table>\n                      <\/jats:table-wrap>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10067-026-07939-w","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:32:57Z","timestamp":1768527177000},"page":"1487-1497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The imbalance of Th17\/Treg cells exists in asymptomatic hyperuricemia (the early stage of gout)"],"prefix":"10.1007","volume":"45","author":[{"given":"Li-qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-lin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-ying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3943-6000","authenticated-orcid":false,"given":"Xiao-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"7939_CR1","unstructured":"George C, Leslie SW, Minter DA (2025) Hyperuricemia. StatPearls. StatPearls Publishing, Treasure Island (FL); [cited 2025 May 6]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459218\/. Accessed 6 May 2025"},{"key":"7939_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041399","volume":"104","author":"W-Z Zhang","year":"2025","unstructured":"Zhang W-Z, Peng Q, Cai X-S, Jiang G-L, Huang J-J, Lu L-L et al (2025) A study on the correlation between hyperuricemia and lifestyle and dietary habits. Medicine 104:e41399. https:\/\/doi.org\/10.1097\/MD.0000000000041399","journal-title":"Medicine"},{"key":"7939_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/nu15224798","volume":"15","author":"C S\u00e1nchez-Bacaicoa","year":"2023","unstructured":"S\u00e1nchez-Bacaicoa C, Santano-Mogena E, Rico-Mart\u00edn S, Rey-S\u00e1nchez P, Ju\u00e1rez-Vela R, S\u00e1nchez Mu\u00f1oz-Torrero JF et al (2023) Association between asymptomatic hyperuricemia with adiposity indices: a cross-sectional study in a Spanish population. Nutrients 15:4798. https:\/\/doi.org\/10.3390\/nu15224798","journal-title":"Nutrients"},{"key":"7939_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/japtr.japtr_144_23","volume":"14","author":"N Parisa","year":"2023","unstructured":"Parisa N, Kamaluddin MT, Saleh MI, Sinaga E (2023) The inflammation process of gout arthritis and its treatment. J Adv Pharm Technol Res 14:166\u2013170. https:\/\/doi.org\/10.4103\/japtr.japtr_144_23","journal-title":"J Adv Pharm Technol Res"},{"key":"7939_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MBP.0000000000000578","volume":"27","author":"K Gruszka","year":"2022","unstructured":"Gruszka K, Dro\u017cd\u017c T, Wojciechowska W, Jankowski P, Terlecki M, Bijak M et al (2022) Effects of uric acid-lowering therapy in patients with essential arterial hypertension. Blood Press Monit 27:152\u2013160. https:\/\/doi.org\/10.1097\/MBP.0000000000000578","journal-title":"Blood Press Monit"},{"key":"7939_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910853","volume":"25","author":"T-K Yao","year":"2024","unstructured":"Yao T-K, Lee R-P, Wu W-T, Chen I-H, Yu T-C, Yeh K-T (2024) Advances in gouty arthritis management: integration of established therapies, emerging treatments, and lifestyle interventions. Int J Mol Sci 25:10853. https:\/\/doi.org\/10.3390\/ijms251910853","journal-title":"Int J Mol Sci"},{"key":"7939_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247616","volume":"13","author":"J Timsans","year":"2024","unstructured":"Timsans J, Palom\u00e4ki A, Kauppi M (2024) Gout and hyperuricemia: a narrative review of their comorbidities and clinical implications. J Clin Med 13:7616. https:\/\/doi.org\/10.3390\/jcm13247616","journal-title":"J Clin Med"},{"key":"7939_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1282890","volume":"14","author":"D Li","year":"2023","unstructured":"Li D, Yuan S, Deng Y, Wang X, Wu S, Chen X et al (2023) The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. Front Immunol 14:1282890. https:\/\/doi.org\/10.3389\/fimmu.2023.1282890","journal-title":"Front Immunol"},{"key":"7939_CR9","doi-asserted-by":"publisher","first-page":"1441503","DOI":"10.3389\/fendo.2024.1441503","volume":"15","author":"L Ma","year":"2024","unstructured":"Ma L, Wang J, Ma L, Wang XM (2024) The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature. Front Endocrinol (Lausanne) 15:1441503. https:\/\/doi.org\/10.3389\/fendo.2024.1441503","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7939_CR10","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/art.41733","volume":"73","author":"X Shen","year":"2021","unstructured":"Shen X, Wang C, Liang N, Liu Z, Li X, Zhu Z-J et al (2021) Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout. Arthritis Rheumatol 73:1738\u20131748. https:\/\/doi.org\/10.1002\/art.41733","journal-title":"Arthritis Rheumatol"},{"key":"7939_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3904\/kjim.2020.340","volume":"36","author":"Y Waheed","year":"2021","unstructured":"Waheed Y, Yang F, Sun D (2021) Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease. Korean J Intern Med 36:1281\u20131293. https:\/\/doi.org\/10.3904\/kjim.2020.340","journal-title":"Korean J Intern Med"},{"key":"7939_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39775-2","volume":"13","author":"Q Yu","year":"2023","unstructured":"Yu Q, Sun Z, Wang Y, Du X, Huang J, Wang L (2023) Hyperuricemia is accompanied by elevated peripheral CD4+ T cells. Sci Rep 13:12537. https:\/\/doi.org\/10.1038\/s41598-023-39775-2","journal-title":"Sci Rep"},{"key":"7939_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107909","volume":"26","author":"G Cab\u0103u","year":"2023","unstructured":"Cab\u0103u G, Gaal O, Badii M, Nica V, Mirea A-M, Hotea I et al (2023) Hyperuricemia remodels the serum proteome toward a higher inflammatory state. iScience 26:107909. https:\/\/doi.org\/10.1016\/j.isci.2023.107909","journal-title":"iScience"},{"key":"7939_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01253-4","volume":"24","author":"X Zi","year":"2024","unstructured":"Zi X, Su R, Su R, Wang H, Li B, Gao C et al (2024) Elevated serum IL-2 and Th17\/Treg imbalance are associated with gout. Clin Exp Med 24:9. https:\/\/doi.org\/10.1007\/s10238-023-01253-4","journal-title":"Clin Exp Med"},{"key":"7939_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101763","volume":"76","author":"L-J Zhao","year":"2023","unstructured":"Zhao L-J, Wang H, Gao H-Y, Wang J, Gao C, Li X-F (2023) Increase in different peripheral effector T subsets in acute and chronic gout. Transpl Immunol 76:101763. https:\/\/doi.org\/10.1016\/j.trim.2022.101763","journal-title":"Transpl Immunol"},{"key":"7939_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20457-1","volume":"24","author":"F Deng","year":"2024","unstructured":"Deng F, Wang Q, Wen X, Xu X, Jia L, He H et al (2024) Association between body mass index and serum uric acid: mediation analysis involving liver enzymes indicators. BMC Public Health 24:3007. https:\/\/doi.org\/10.1186\/s12889-024-20457-1","journal-title":"BMC Public Health"},{"key":"7939_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9030061","volume":"9","author":"S Deb","year":"2021","unstructured":"Deb S, Sakharkar P (2021) A population based study of liver function amongst adults with hyperuricemia and gout in the United States. Diseases 9:61. https:\/\/doi.org\/10.3390\/diseases9030061","journal-title":"Diseases"},{"key":"7939_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1367621","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Xie Y, Li J, Chang Z, Zhang J, Zhou Z et al (2024) Diastolic and systolic blood pressure and gout: a Mendelian randomization study. Front Endocrinol (Lausanne) 15:1367621. https:\/\/doi.org\/10.3389\/fendo.2024.1367621","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7939_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1031-6","volume":"18","author":"Y-L Hou","year":"2019","unstructured":"Hou Y-L, Yang X-L, Wang C-X, Zhi L-X, Yang M-J, You C-G (2019) Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents. Lipids Health Dis 18:81. https:\/\/doi.org\/10.1186\/s12944-019-1031-6","journal-title":"Lipids Health Dis"},{"key":"7939_CR20","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W Liu","year":"2006","unstructured":"Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203:1701\u20131711. https:\/\/doi.org\/10.1084\/jem.20060772","journal-title":"J Exp Med"},{"key":"7939_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008329","volume":"96","author":"G Luo","year":"2017","unstructured":"Luo G, Yi T, Zhang G, Guo X, Jiang X (2017) Increased circulating Th22 cells in patients with acute gouty arthritis: a CONSORT-compliant article. Medicine (Baltimore) 96:e8329. https:\/\/doi.org\/10.1097\/MD.0000000000008329","journal-title":"Medicine (Baltimore)"},{"key":"7939_CR22","first-page":"21460","volume":"8","author":"X Feng","year":"2015","unstructured":"Feng X, Li Y, Gao W (2015) Prophylaxis on gout flares after the initiation of urate-lowering therapy: a retrospective research. Int J Clin Exp Med 8:21460\u201321465","journal-title":"Int J Clin Exp Med"},{"key":"7939_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2022.170834","volume":"155","author":"EM da Silva","year":"2022","unstructured":"da Silva EM, Yariwake VY, Alves RW, de Araujo DR, Andrade-Oliveira V (2022) Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases. Peptides 155:170834. https:\/\/doi.org\/10.1016\/j.peptides.2022.170834","journal-title":"Peptides"},{"key":"7939_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molimm.2024.05.003","volume":"171","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang J, Fang Y, Liang W, Lei L, Wang J et al (2024) IFN-\u03b1 affects Th17\/Treg cell balance through c-Maf and associated with the progression of EBV- SLE. Mol Immunol 171:22\u201335. https:\/\/doi.org\/10.1016\/j.molimm.2024.05.003","journal-title":"Mol Immunol"},{"key":"7939_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104351","volume":"147","author":"F Raucci","year":"2019","unstructured":"Raucci F, Iqbal AJ, Saviano A, Minosi P, Piccolo M, Irace C et al (2019) IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation. Pharmacol Res 147:104351. https:\/\/doi.org\/10.1016\/j.phrs.2019.104351","journal-title":"Pharmacol Res"},{"key":"7939_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156502","volume":"175","author":"R Liu","year":"2024","unstructured":"Liu R, Kl\u00fcck V, Kischkel B, Tercan H, Netea MG, Cri\u015fan TO et al (2024) Soluble urate-induced effects on cytokine production in vitro - assessment of methodologies and cell types. Cytokine 175:156502. https:\/\/doi.org\/10.1016\/j.cyto.2024.156502","journal-title":"Cytokine"},{"key":"7939_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3349\/ymj.2022.63.3.241","volume":"63","author":"HW Kim","year":"2022","unstructured":"Kim HW, Yoon E-J, Jeong SH, Park M-C (2022) Distinct gut microbiota in patients with asymptomatic hyperuricemia: a potential protector against gout development. Yonsei Med J 63:241\u2013251. https:\/\/doi.org\/10.3349\/ymj.2022.63.3.241","journal-title":"Yonsei Med J"},{"key":"7939_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803101","volume":"12","author":"P Chen","year":"2021","unstructured":"Chen P, Tang X (2021) Gut microbiota as regulators of Th17\/Treg balance in patients with myasthenia gravis. Front Immunol 12:803101. https:\/\/doi.org\/10.3389\/fimmu.2021.803101","journal-title":"Front Immunol"},{"key":"7939_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445639","volume":"15","author":"R Pei","year":"2024","unstructured":"Pei R, Wang J, He P, Yu Q, Zhang S, Shi G et al (2024) Risk factors for type 2 diabetes mellitus in Chinese rheumatoid arthritis patients from 2018 to 2022: a real-world, single-center, retrospective study. Front Immunol 15:1445639. https:\/\/doi.org\/10.3389\/fimmu.2024.1445639","journal-title":"Front Immunol"},{"key":"7939_CR30","doi-asserted-by":"publisher","first-page":"16171","DOI":"10.20452\/pamw.16171","volume":"132","author":"AM Imiela","year":"2022","unstructured":"Imiela AM, Miko\u0142ajczyk TP, Siedli\u0144ski M, Dobrowolski P, Konior-Rozlachowska A, Wr\u00f3bel A et al (2022) Th17\/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertension. Pol Arch Intern Med 132:16171. https:\/\/doi.org\/10.20452\/pamw.16171","journal-title":"Pol Arch Intern Med"},{"key":"7939_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2018.09.005","volume":"197","author":"M Wang","year":"2018","unstructured":"Wang M, Chen F, Wang J, Zeng Z, Yang Q, Shao S (2018) Th17 and Treg lymphocytes in obesity and type 2 diabetic patients. Clin Immunol 197:77\u201385. https:\/\/doi.org\/10.1016\/j.clim.2018.09.005","journal-title":"Clin Immunol"},{"key":"7939_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70079","volume":"28","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qiu M, Zhou L, Zheng X, Wu X, Tu L et al (2025) The association of persistent hyperuricemia with liver function and the management of uric acid levels: insights from a three-year prospective cohort study. Int J Rheum Dis 28:e70079. https:\/\/doi.org\/10.1111\/1756-185X.70079","journal-title":"Int J Rheum Dis"},{"key":"7939_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058793","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xu F, Zhang X, Mi F, Qian Y, Hong R et al (2022) Cross-sectional association between gamma-glutamyl transferase and hyperuricaemia: the China multi-ethinic cohort (CMEC) study. BMJ Open 12:e058793. https:\/\/doi.org\/10.1136\/bmjopen-2021-058793","journal-title":"BMJ Open"},{"key":"7939_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1326039","volume":"11","author":"Y Niu","year":"2024","unstructured":"Niu Y, Zhang Y, Sun Y, Sheng J, Lu W, Li J et al (2024) A combined association of obesity, alanine aminotransferase and creatinine with hyperuricemia in youth aged 13-20 years. Front Nutr 11:1326039. https:\/\/doi.org\/10.3389\/fnut.2024.1326039","journal-title":"Front Nutr"},{"key":"7939_CR35","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3748\/wjg.v26.i15.1683","volume":"26","author":"P Brennan","year":"2020","unstructured":"Brennan P, Clare K, George J, Dillon JF (2020) Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: an opinion review. World J Gastroenterol 26:1683\u20131690. https:\/\/doi.org\/10.3748\/wjg.v26.i15.1683","journal-title":"World J Gastroenterol"},{"key":"7939_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jare.2016.11.004","volume":"8","author":"UAA Sharaf El Din","year":"2017","unstructured":"Sharaf El Din UAA, Salem MM, Abdulazim DO (2017) Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review. J Adv Res 8:537\u2013548. https:\/\/doi.org\/10.1016\/j.jare.2016.11.004","journal-title":"J Adv Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07939-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07939-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07939-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:02Z","timestamp":1769763722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07939-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7939"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07939-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fenyang Hospital, Shanxi (Approval Number: 2022045).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All persons gave their informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. We have full control of all primary data and that agree to\u00a0allow the journal to review our data if requested.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}